Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C round brings in $45.2mm for EnteroMedics

Executive Summary

EnteroMedics (devices for obesity and gastrointestinal disorders) raised $45.2mm in its third financing round led by new investor InterWest Partners. Other first-time backers Onset Ventures, Pacific Asset Partners, and the Mayo Foundation for Medical Education and Research (with whom the company has a 2005 obesity agreement) participated along with all returning shareholders MPM Capital, Bay City Capital, Aberdare Ventures, and Charter Life Sciences.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies